Simon Retter, Chairman

Mr. Retter has extensive listed company experience and is also Fellow of the Institute of Chartered Accountants in England & Wales. He was founder of Adalan Ventures Plc, has also been Finance Director of SulNox Group plc amongst numerous other listed company directorships and currently holds the position of Non-Executive Director at ElixIrr International plc. Mr. Retter received an undergraduate degree from the University of Bristol.

David Brown, IAB Member (Non-Board)

David S. Brown is a relentless innovator driven by curiosity and tenacity. From pioneering internet search at OpenText to powering the rise of e-commerce at Commerce One, he’s consistently ahead of the curve. A founding influence behind Level39 and the fintech explosion, David thrives where others hesitate — spotting seismic shifts early and backing them with conviction. Now leading FPP’s AI charge, he’s hunting the next breakthrough with the same unstoppable drive.

Richard Samuel, NED

Mr. Samuel is the Chief Investment Officer of the Lotus Energy Group, a global energy infrastructure provider with a focus on the deployment of distributed generation and micro-grid projects employing gas turbine, solar and wind power generating technologies.

He has over 25 years in the global financial buyout market and has deep experience in raising debt and equity financing for privately held companies. Previous roles include senior executive positions at leading European financial institutions, including Alcentra limited (investment subsidiary of Bank of New York Mellon), Intermediate Capital Group and Deutsche Bank/Morgan Grenfell.

Mr Samuel holds several Non-Executive board positions which include: Simplisim Group Limited, PR Facilities Management Limited and SGC Wine Limited; was a graduate of the University of Toronto (B. Comm), and is a Chartered Financial Analyst.

Mahesh Pulandaran, NED

Mr. Pulandaran is based in Singapore and has sat on the board of Fragrant Prosperity Holdings since its founding. In his career, Mr. Pulandran advised various blue chip companies including Microsoft Corp and Caterpillar Inc.

Dr. Daniel Reshef, NED

Dr. Reshef is a dual Israeli and USA Citizen, currently living in the USA, with strong ties in the global pharmaceutical sector.

Dr Reshef’s extensive career with over twenty five years in drug development encompasses many facets of the Pharmaceutical sector, gained through senior management positions at leading companies such as Hoffman La Roche, Genentech, Bristol Myers Squibb, and in his current capacity as the Therapeutic Area Global Head for a major global Pharmaceutical Company. His scientific experience includes skills in regulatory, medical affairs, drug safety operations and clinical trials epidemiology with leadership experience in early drug development from phase 1 to phase IV, and in multiple therapeutic areas.

Dr. Reshef is a board-certified physician, graduate of the Hebrew University and Hadassah Medical School in Jerusalem, and has earned his MPH and PhD in Epidemiology from Johns Hopkins University.

Investment Advisory Board

The Investment Advisory Board (“IAB”) has been established to support the identification and evaluation of acquisition targets, with a focus on the transformative potential of artificial intelligence in financial services. It comprises Simon Retter as Chair, with Richard Samuel and David Brown being the other members.